FAEGRE DRINKER BIDDLE & REATH LLP — Lobbying Disclosure | Poliscope

FAEGRE DRINKER BIDDLE & REATH LLP

View full entity profile (contributions, contracts, SEC) →

Lobbying Income

$89.2M

Filings

4,906

Unique Clients

Active Period

1999–2026

Lobbying Income by Year

Registrant-reported income from clients on LDA filings

Year	Lobbying Income	Filings	Clients
2026	$2,550,000	123	46
2025	$3,882,000	174	43
2024	$2,960,300	174	45
2023	$3,650,000	186	49
2022	$4,235,000	236	78
2021	$5,830,000	321	94
2020	$5,310,000	365	84
2019	$3,590,000	182	48
2018	$3,590,000	167	44
2017	$3,430,000	161	43
2016	$3,625,000	167	42
2015	$3,410,000	154	40
2014	$3,620,000	160	56
2013	$5,375,000	253	61
2012	$5,350,000	275	75
2011	$5,500,000	298	80
2010	$6,045,000	329	87
2009	$5,606,000	364	96
2008	$5,360,000	370	95
2007	$4,650,000	253	93
2006	$240,000	35	21
2005	$320,000	26	18
2004	$260,000	31	19
2003	$340,000	23	16
2002	$133,100	28	15
2001	$280,000	25	12
2000	$40,000	10	7
1999	—	16	9

Top Clients

Largest clients by registrant-reported income

Client	Reported Income	Filings	Period
SHIRLEY RYAN ABILITYLAB	$2,640,000	77	2007–2025
ADVOCATE AURORA HEALTH INC	$2,620,000	62	2007–2022
NATIONAL ATHLETIC TRAINERS' ASSOCIATION	$2,530,000	56	2008–2022
AMERICAN ASSOCIATION OF BIOANALYSTS	$2,470,000	43	2007–2017
CONVATEC	$2,290,000	51	2008–2019
AMERICAN SOCIETY OF TROPICAL MEDICINE AND HYGIENE	$2,130,000	62	2007–2022
WISCONSIN ALUMNI RESEARCH FOUNDATION	$1,950,700	55	2002–2018
THE REHABILITATION INNOVATION CENTERS COALITION	$1,770,000	58	2012–2026
WHOLESALE & SPECIALTY INSURANCE ASSOCIATION	$1,665,000	28	2020–2025
NATIONAL OPINION RESEARCH CENTER AT THE UNIVERSITY OF CHICAGO	$1,650,000	39	2010–2018
ALLIANCE FOR BIOSECURITY	$1,630,000	42	2007–2017
ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL)	$1,605,000	28	2020–2026
CONFEDERATED TRIBES OF THE COLVILLE RESERVATION	$1,600,000	28	2007–2014
NATIONAL PSORIASIS FOUNDATION	$1,480,000	40	2007–2023
SPINA BIFIDA ASSOCIATION	$1,420,000	60	2007–2022
PROGRAM FOR APPROPRIATE TECHNOLOGY IN HEALTH	$1,320,000	47	2008–2022
AMERICAN NEPHROLOGY NURSES ASSOCIATION	$1,310,000	61	2007–2022
PREVENT BLINDNESS	$1,225,000	41	2008–2018
ASSOCIATION OF REHABILITATION NURSES	$1,200,000	51	2007–2019
HEMATOLOGY/ONCOLOGY PHARMACY ASSOCIATION	$1,090,000	32	2012–2019
SMITH & NEPHEW INC	$1,070,000	23	2011–2016
AMERICAN DIABETES ASSOCIATION	$1,065,000	43	2009–2019
STATION CASINOS INC	$1,060,000	31	2007–2014
ONCOLOGY NURSING SOCIETY	$1,040,000	29	2007–2013
BROADCAST MUSIC INC	$975,000	50	2000–2017

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	2,894
SENATE	2,805
Health & Human Services, Dept of (HHS)	522
Centers For Medicare and Medicaid Services (CMS)	393
Interior, Dept of (DOI)	375
Natl Institutes of Health (NIH)	271
White House Office	213
Food & Drug Administration (FDA)	206
Centers For Disease Control & Prevention (CDC)	192
Office of Management & Budget (OMB)	178
Energy, Dept of	168
Health Resources & Services Administration (HRSA)	109
Defense, Dept of (DOD)	94
Bureau of Indian Affairs (BIA)	80
Commerce, Dept of (DOC)	73
Education, Dept of	69
Executive Office of the President (EOP)	68
Environmental Protection Agency (EPA)	64
Justice, Dept of (DOJ)	55
Patent & Trademark Office (PTO)	55

Top Issues Lobbied

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	1,453
Budget/Appropriations	Budget/Appropriations	1,267
Medicare/Medicaid	Medicare/Medicaid	920
Indian/Native American Affairs	Indian/Native American Affairs	427
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	418
Copyright/Patent/Trademark	Copyright/Patent/Trademark	203
Energy/Nuclear	Energy/Nuclear	154
Education	Education	145
Taxation/Internal Revenue Code	Taxation/Internal Revenue Code	110
Trade (domestic/foreign)	Trade (domestic/foreign)	96
Pharmacy	Pharmacy	87
Foreign Relations	Foreign Relations	82
Food Industry (safety, labeling, etc.)	Food Industry (safety, labeling, etc.)	81
Science/Technology	Science/Technology	61
Veterans	Veterans	61
Environment/Superfund	Environment/Superfund	60
Defense	Defense	58
Gaming/Gambling/Casino	Gaming/Gambling/Casino	54
Insurance	Insurance	53
Telecommunications	Telecommunications	49

Bills Explicitly Cited (25)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 1394119th Congress

CURD Act

2026 · third_quarter · Client: SARGENTO FOODS INC.

Open original LDA filing ↗

Cited source text and reported amounts

Food issues; Issues related to natural cheese; H.R. 1394/S.184, the Codifying Useful Regulatory Definitions Act (CURD) Act; H.R. 1394 / S. 184, the Codifying Useful Regulatory Definitions Act.

Client expense: — · Firm income: $10,000

Matched citations: H.R. 1394

S. 184119th Congress

CURD Act

2026 · third_quarter · Client: SARGENTO FOODS INC.

Open original LDA filing ↗

Cited source text and reported amounts

Food issues; Issues related to natural cheese; H.R. 1394/S.184, the Codifying Useful Regulatory Definitions Act (CURD) Act; H.R. 1394 / S. 184, the Codifying Useful Regulatory Definitions Act.

Client expense: — · Firm income: $10,000

Matched citations: S. 184, S.184

H.R. 10443119th Congress

American Procurement Improvement Act of 2026

2026 · third_quarter · Client: IFB SOLUTIONS

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to AbilityOne program; H.R. 2804 / S. 2656, the Protecting Small Business Competitions Act; H.R. 10443, the American Procurement Improvement Act.

Client expense: — · Firm income: $20,000

Matched citations: H.R. 10443

H.R. 2804119th Congress

Protecting Small Business Competitions Act of 2026

2026 · third_quarter · Client: IFB SOLUTIONS

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to AbilityOne program; H.R. 2804 / S. 2656, the Protecting Small Business Competitions Act; H.R. 10443, the American Procurement Improvement Act.

Client expense: — · Firm income: $20,000

Matched citations: H.R. 2804

Show 21 more cited filings

S. 2656119th Congress

Protecting Small Business Competitions Act of 2025

2026 · third_quarter · Client: IFB SOLUTIONS

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to AbilityOne program; H.R. 2804 / S. 2656, the Protecting Small Business Competitions Act; H.R. 10443, the American Procurement Improvement Act.

Client expense: — · Firm income: $20,000

Matched citations: S. 2656

H.R. 6280119th Congress

Access to Genetic Counselor Services Act of 2025

2026 · third_quarter · Client: THE NATIONAL SOCIETY OF GENETIC COUNSELORS

Open original LDA filing ↗

Cited source text and reported amounts

Access to Genetic Counselor Services Act, H.R. 6280/S. 3607; NIH funding; newborn screening; regulation of genetic testing and genetic counseling; Medicaid coverage; telehealth access; Reducing Hereditary Cancer Act.

Client expense: — · Firm income: $60,000

Matched citations: H.R. 6280

S. 3607119th Congress

Access to Genetic Counselor Services Act of 2026

2026 · third_quarter · Client: THE NATIONAL SOCIETY OF GENETIC COUNSELORS

Open original LDA filing ↗

Cited source text and reported amounts

Access to Genetic Counselor Services Act, H.R. 6280/S. 3607; NIH funding; newborn screening; regulation of genetic testing and genetic counseling; Medicaid coverage; telehealth access; Reducing Hereditary Cancer Act.

Client expense: — · Firm income: $60,000

Matched citations: S. 3607

H.R. 1843119th Congress

To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.

2026 · third_quarter · Client: TEVA PHARMACEUTICALS USA INC

Open original LDA filing ↗

Cited source text and reported amounts

Skinny Labels, Big Savings Act (S 43). Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals (S 1096, HR 1843). Implementation of Inflation Reduction Act pricing proposal. Oversight and reform efforts affecting pharmacy benefit managers. Patent reform (S 1095, S 1097). Proposals related to drug shortages. Proposals related to pharmaceutical tariffs; Proposals related to drug pricing reform; Schizophrenia treatment awareness.

Client expense: — · Firm income: $60,000

Matched citations: HR 1843

H.R. 1843119th Congress

To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.

2026 · third_quarter · Client: TEVA PHARMACEUTICALS USA INC

Open original LDA filing ↗

Cited source text and reported amounts

Skinny Labels, Big Savings Act (S 43). Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals (S 1096, HR 1843). Implementation of Inflation Reduction Act pricing proposal. Oversight and reform efforts affecting pharmacy benefit managers. Patent reform (S 1095, S 1097). Proposals related to drug shortages. Proposals related to pharmaceutical tariffs; Proposals related to drug pricing reform; Schizophrenia treatment awareness.

Client expense: — · Firm income: $60,000

Matched citations: HR 1843

S. 1095119th Congress

Stop STALLING Act

2026 · third_quarter · Client: TEVA PHARMACEUTICALS USA INC

Open original LDA filing ↗

Cited source text and reported amounts

Skinny Labels, Big Savings Act (S 43). Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals (S 1096, HR 1843). Implementation of Inflation Reduction Act pricing proposal. Oversight and reform efforts affecting pharmacy benefit managers. Patent reform (S 1095, S 1097). Proposals related to drug shortages. Proposals related to pharmaceutical tariffs; Proposals related to drug pricing reform; Schizophrenia treatment awareness.

Client expense: — · Firm income: $60,000

Matched citations: S 1095

S. 1095119th Congress

Stop STALLING Act

2026 · third_quarter · Client: TEVA PHARMACEUTICALS USA INC

Open original LDA filing ↗

Cited source text and reported amounts

Skinny Labels, Big Savings Act (S 43). Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals (S 1096, HR 1843). Implementation of Inflation Reduction Act pricing proposal. Oversight and reform efforts affecting pharmacy benefit managers. Patent reform (S 1095, S 1097). Proposals related to drug shortages. Proposals related to pharmaceutical tariffs; Proposals related to drug pricing reform; Schizophrenia treatment awareness.

Client expense: — · Firm income: $60,000

Matched citations: S 1095

S. 1096119th Congress

Preserve Access to Affordable Generics and Biosimilars Act

2026 · third_quarter · Client: TEVA PHARMACEUTICALS USA INC

Open original LDA filing ↗

Cited source text and reported amounts

Skinny Labels, Big Savings Act (S 43). Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals (S 1096, HR 1843). Implementation of Inflation Reduction Act pricing proposal. Oversight and reform efforts affecting pharmacy benefit managers. Patent reform (S 1095, S 1097). Proposals related to drug shortages. Proposals related to pharmaceutical tariffs; Proposals related to drug pricing reform; Schizophrenia treatment awareness.

Client expense: — · Firm income: $60,000

Matched citations: S 1096

S. 1096119th Congress

Preserve Access to Affordable Generics and Biosimilars Act

2026 · third_quarter · Client: TEVA PHARMACEUTICALS USA INC

Open original LDA filing ↗

Cited source text and reported amounts

Skinny Labels, Big Savings Act (S 43). Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals (S 1096, HR 1843). Implementation of Inflation Reduction Act pricing proposal. Oversight and reform efforts affecting pharmacy benefit managers. Patent reform (S 1095, S 1097). Proposals related to drug shortages. Proposals related to pharmaceutical tariffs; Proposals related to drug pricing reform; Schizophrenia treatment awareness.

Client expense: — · Firm income: $60,000

Matched citations: S 1096

S. 1097119th Congress

Interagency Patent Coordination and Improvement Act of 2025

2026 · third_quarter · Client: TEVA PHARMACEUTICALS USA INC

Open original LDA filing ↗

Cited source text and reported amounts

Skinny Labels, Big Savings Act (S 43). Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals (S 1096, HR 1843). Implementation of Inflation Reduction Act pricing proposal. Oversight and reform efforts affecting pharmacy benefit managers. Patent reform (S 1095, S 1097). Proposals related to drug shortages. Proposals related to pharmaceutical tariffs; Proposals related to drug pricing reform; Schizophrenia treatment awareness.

Client expense: — · Firm income: $60,000

Matched citations: S 1097

S. 1097119th Congress

Interagency Patent Coordination and Improvement Act of 2025

2026 · third_quarter · Client: TEVA PHARMACEUTICALS USA INC

Open original LDA filing ↗

Cited source text and reported amounts

Skinny Labels, Big Savings Act (S 43). Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals (S 1096, HR 1843). Implementation of Inflation Reduction Act pricing proposal. Oversight and reform efforts affecting pharmacy benefit managers. Patent reform (S 1095, S 1097). Proposals related to drug shortages. Proposals related to pharmaceutical tariffs; Proposals related to drug pricing reform; Schizophrenia treatment awareness.

Client expense: — · Firm income: $60,000

Matched citations: S 1097

S. 43119th Congress

Skinny Labels, Big Savings Act

2026 · third_quarter · Client: TEVA PHARMACEUTICALS USA INC

Open original LDA filing ↗

Cited source text and reported amounts

Skinny Labels, Big Savings Act (S 43). Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals (S 1096, HR 1843). Implementation of Inflation Reduction Act pricing proposal. Oversight and reform efforts affecting pharmacy benefit managers. Patent reform (S 1095, S 1097). Proposals related to drug shortages. Proposals related to pharmaceutical tariffs; Proposals related to drug pricing reform; Schizophrenia treatment awareness.

Client expense: — · Firm income: $60,000

Matched citations: S 43

S. 43119th Congress

Skinny Labels, Big Savings Act

2026 · third_quarter · Client: TEVA PHARMACEUTICALS USA INC

Open original LDA filing ↗

Cited source text and reported amounts

Skinny Labels, Big Savings Act (S 43). Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals (S 1096, HR 1843). Implementation of Inflation Reduction Act pricing proposal. Oversight and reform efforts affecting pharmacy benefit managers. Patent reform (S 1095, S 1097). Proposals related to drug shortages. Proposals related to pharmaceutical tariffs; Proposals related to drug pricing reform; Schizophrenia treatment awareness.

Client expense: — · Firm income: $60,000

Matched citations: S 43

H.R. 2483119th Congress

SUPPORT for Patients and Communities Reauthorization Act of 2025

2026 · third_quarter · Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY

Open original LDA filing ↗

Cited source text and reported amounts

Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act; CMS DMEPOS accreditation program.

Client expense: — · Firm income: $30,000

Matched citations: H.R. 2483

H.R. 929119th Congress

Dr. Lorna Breen Health Care Provider Protection Reauthorization Act

2026 · third_quarter · Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY

Open original LDA filing ↗

Cited source text and reported amounts

Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act; CMS DMEPOS accreditation program.

Client expense: — · Firm income: $30,000

Matched citations: HR 929

S. 3794119th Congress

SAFE Drugs Act of 2026

2026 · third_quarter · Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY

Open original LDA filing ↗

Cited source text and reported amounts

Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules; CMS DMEPOS accreditation program; S. 3794 SAFE Drugs Act.

Client expense: — · Firm income: $30,000

Matched citations: S. 3794

H.R. 139119th Congress

Sunshine Protection Act of 2025

2026 · third_quarter · Client: AMERICAN ACADEMY OF NEUROLOGY

Open original LDA filing ↗

Cited source text and reported amounts

Support BRAIN Initiative and VA Neurology Centers of Excellence appropriations; Support H.R. 9693 Patients First Act; Support H.R. 5509/S. 2903 SAFE STEP Act; Support H.R. 3514/S.1816 Seniors Timely Access to Care Act; Support H.R. 929/S. 266 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act; Support H.R. 7961 H-1B Visas for Physicians and the Healthcare Workforce Act; Oppose H.R. 139 Sunshine Protection Act.

Client expense: — · Firm income: $50,000

Matched citations: H.R. 139

H.R. 3514119th Congress

Improving Seniors’ Timely Access to Care Act of 2025

2026 · third_quarter · Client: AMERICAN ACADEMY OF NEUROLOGY

Open original LDA filing ↗

Cited source text and reported amounts

Support BRAIN Initiative and VA Neurology Centers of Excellence appropriations; Support H.R. 9693 Patients First Act; Support H.R. 5509/S. 2903 SAFE STEP Act; Support H.R. 3514/S.1816 Seniors Timely Access to Care Act; Support H.R. 929/S. 266 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act; Support H.R. 7961 H-1B Visas for Physicians and the Healthcare Workforce Act; Oppose H.R. 139 Sunshine Protection Act.

Client expense: — · Firm income: $50,000

Matched citations: H.R. 3514

H.R. 5509119th Congress

Safe Step Act

2026 · third_quarter · Client: AMERICAN ACADEMY OF NEUROLOGY

Open original LDA filing ↗

Cited source text and reported amounts

Support BRAIN Initiative and VA Neurology Centers of Excellence appropriations; Support H.R. 9693 Patients First Act; Support H.R. 5509/S. 2903 SAFE STEP Act; Support H.R. 3514/S.1816 Seniors Timely Access to Care Act; Support H.R. 929/S. 266 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act; Support H.R. 7961 H-1B Visas for Physicians and the Healthcare Workforce Act; Oppose H.R. 139 Sunshine Protection Act.

Client expense: — · Firm income: $50,000

Matched citations: H.R. 5509

H.R. 7961119th Congress

H–1Bs for Physicians and the Healthcare Workforce Act

2026 · third_quarter · Client: AMERICAN ACADEMY OF NEUROLOGY

Open original LDA filing ↗

Cited source text and reported amounts

Support BRAIN Initiative and VA Neurology Centers of Excellence appropriations; Support H.R. 9693 Patients First Act; Support H.R. 5509/S. 2903 SAFE STEP Act; Support H.R. 3514/S.1816 Seniors Timely Access to Care Act; Support H.R. 929/S. 266 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act; Support H.R. 7961 H-1B Visas for Physicians and the Healthcare Workforce Act; Oppose H.R. 139 Sunshine Protection Act.

Client expense: — · Firm income: $50,000

Matched citations: H.R. 7961

H.R. 929119th Congress

Dr. Lorna Breen Health Care Provider Protection Reauthorization Act

2026 · third_quarter · Client: AMERICAN ACADEMY OF NEUROLOGY

Open original LDA filing ↗

Cited source text and reported amounts

Support BRAIN Initiative and VA Neurology Centers of Excellence appropriations; Support H.R. 9693 Patients First Act; Support H.R. 5509/S. 2903 SAFE STEP Act; Support H.R. 3514/S.1816 Seniors Timely Access to Care Act; Support H.R. 929/S. 266 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act; Support H.R. 7961 H-1B Visas for Physicians and the Healthcare Workforce Act; Oppose H.R. 139 Sunshine Protection Act.

Client expense: — · Firm income: $50,000

Matched citations: H.R. 929

Source: Senate LDA